"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors"

NCT05355597 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

116

Enrollment

OTHER

Sponsor class

Stopped Physician left institution

Conditions

Musculoskeletal Diseases
Soft Tissue Mass

Interventions

DRUG: Exparel Injectable Product
DRUG: Multi-Drug Cocktail (Ropivicaine, Epinephrine, Ketolorac, Clonidine)

Sponsor

Atlantic Health System